How to cite item

Pharmacological activation of REV-ERBα represses LPSinduced microglial activation through the NF-κB pathway

   
@article{APS9898,
	author = {Dong-kai Guo and Yao Zhu and Hong-yang Sun and Xing-yun Xu and Shun Zhang and Zong-bing Hao and Guang-hui Wang and Chen-chen Mu and Hai-gang Ren},
	title = {Pharmacological activation of REV-ERBα represses LPSinduced microglial activation through the NF-κB pathway},
	journal = {Acta Pharmacologica Sinica},
	volume = {40},
	number = {1},
	year = {2018},
	keywords = {},
	abstract = {REV-ERBα, the NR1D1 (nuclear receptor subfamily 1, group D, member 1) gene product, is a dominant transcriptional silencer that represses the expression of genes involved in numerous physiological functions, including circadian rhythm, inflammation, and metabolism, and plays a crucial role in maintaining immune functions. Microglia-mediated neuroinflammation is tightly associated with various neurodegenerative diseases and psychiatric disorders. However, the role of REV-ERBα in neuroinflammation is largely unclear. In this study, we investigated whether and how pharmacological activation of REV-ERBα affected lipopolysaccharide (LPS)-induced neuroinflammation in mouse microglia in vitro and in vivo. In BV2 cells or primary mouse cultured microglia, application of REV-ERBα agonist GSK4112 or SR9011 dose-dependently suppressed LPS-induced microglial activation through the nuclear factor kappa B (NF-κB) pathway. In BV2 cells, pretreatment with GSK4112 inhibited LPS-induced phosphorylation of the inhibitor of NF-κB alpha (IκBα) kinase (IκK), thus restraining the phosphorylation and degradation of IκBα, and blocked the nuclear translocation of p65, a NF-κB subunit, thereby suppressing the expression and secretion of the proinflammatory cytokines, such as interleukin 6 (IL-6) and tumor necrosis factor α (TNFα). Moreover, REV-ERBα agonist-induced inhibition on neuroinflammation protected neurons from microglial activation-induced damage, which were also demonstrated in mice with their ventral midbrain microinjected with GSK4112, and then stimulated with LPS. Our results reveal that enhanced REV-ERBα activity suppresses microglial activation through the NF-κB pathway in the central nervous system.},
	issn = {1745-7254},	url = {http://www.chinaphar.com/article/view/9898}
}